NOS2 mediates opposing effects in models of acute and chronic cardiac rejection: Insights from NOS2-knockout mice

American Journal of Pathology

Volumn 153, Issue 5, 1998, Pages 1371-1376

  Koglin, Jörg ^a   Glysing Jensen, Troels ^a   Mudgett, John S ^d   Russell, Mary E ^a,b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; NITRIC OXIDE;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; HEART TRANSPLANTATION; HEART VENTRICLE CONTRACTILITY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031768307     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65723-9     Document Type: Article

References (19)

1. McManus BM, Winters GL: Pathology of heart allogratt rejection. In Transplant Pathology: Clinical and Anatomical Principles. Edited by PC Kolbeck, RS Markin, BM McManus. Chicago, ASCP Press, 1994, pp 197-218
2. Yang X, Chowdhury N, Cai B, Brett J, Marboe C, Sciacca RR, Michler RE, Cannon PJ: Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest. 1994, 94:714-721
3. Russell ME, Wallace AF, Wyner LR, Newell JB, Karnovsky MJ: Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis. Circulation. 1995, 92:457-464
4. Worrall NK, Lazenby WD, Misko TP, Lin TS, Rodi CP, Manning PT, Tilton RG, Williamson JR, Ferguson TB, Jr: Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med. 1995, 181:63-70
5. Winlaw DS, Schyvens CG, Smythe GA, Du ZY, Rainer SP, Lord RS, Spratt PM, Macdonald PS: Selective inhibition of nitric oxide production during cardiac allograft rejection causes a small increase in graft survival. Transplantation 1995, 60:77-82
6. Shiraishi T, DeMeester SR, Worrall NK, Ritter JH, Misko TP, Ferguson TB, Jr., Cooper JD, Patterson GA: Inhibition of inducible nitric oxide synthase ameliorates rat lung allograft rejection. J Thorac Cardiovasc Surg 1995, 110:1449-1459; discussion 1460
7. Paul LC, Myllarniemi M, Muzaffar S, Benediktsson H: Nitric oxide synthase inhibition is associated with decreased survival of cardiac allografts in the rat. Transplantation 1996, 62:1193-1195
8. Worrall NK, Boasquevisque CH, Botney MD, Misko TP, Sullivan PM, Ritter JH, Ferguson TB, Jr., Patterson GA: Inhibition of inducible nitric oxide synthase ameliorates functional and histological changes of acute lung allograft rejection. Transplantation 1997, 63:1095-1101
9. Koglin J, Glysing-Jensen T, Mudgett JS, Russell ME: Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circulation 1998, 97:2059-2065
10. Corry RJ, Winn HJ, Russell PS: Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973, 16:343-350
11. Räisänen-Sokolowski A, Glysing-Jensen T, Mottram PL, Russell ME: Sustained anti-CD4/CD8 blocks inflammatory activation and intimai thickening in mouse heart allografts. Arterioscler Thromb Vasc Biol 1997, 17:2115-2122
12. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, Chen H, Mudgett JS: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase [published erratum appears in Cell 1995, 81:following 1170]. Cell 1995, 81:641-650
13. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant. 1990, 9:587-593
14. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C: Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992, 256: 225-228
15. Pinsky DJ, Cai B, Yang X, Rodriguez C, Sciacca RR, Cannon PJ: The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor β. J Clin Invest 1995, 95:677-685
16. Szabolcs M, Michler RE, Yang X, Aji W, Roy D, Athan E, Sciacca RR, Minanov OP, Cannon PJ: Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. Circulation 1996, 94:1665-1673
17. Kawaguchi H, Shin WS, Wang Y, Inukai M, Kato M, Matsuo-Okai Y, Sakamoto A, Uehara Y, Kaneda Y, Toyo-oka T: In vivo gene transfection of human endothelial cell nitric oxide synthase in cardiomyocytes causes apoptosis-like cell death: identification using Sendai virus-coated liposomes. Circulation 1997;95:2441-2447
18. Loscalzo J, Welch G: Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 1995, 38:87-104
19. Paul LC, Fellstrom B: Chronic vascular rejection of the heart and the kidney-have rational treatment options emerged? Transplantation 1992, 53:1169-1179